OCULOAURICULOVERTEBRAL DYSPLASIA

OCULOAURICULOVERTEBRAL DYSPLASIA was reported 72 times

OCULOAURICULOVERTEBRAL DYSPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 5 0.0004
1 Mood Stabilizer [EPC] 13 0.0001
2 Anti-epileptic Agent [EPC] 13 0.0001
3 Nitroimidazole Antimicrobial [EPC] 3 0.0000
4 Progesterone [EPC] 1 0.0000
5 Vitamin D [EPC] 6 0.0000
6 Vitamin B12 [EPC] 6 0.0000
7 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
8 Vitamin C [EPC] 6 0.0000
9 Cardiac Glycoside [EPC] 1 0.0000
10 Nonsteroidal Anti-inflammatory Drug [EPC] 14 0.0000
11 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
12 Retinoid [EPC] 1 0.0000
13 Osmotic Laxative [EPC] 1 0.0000
14 Corticosteroid [EPC] 4 0.0000
15 Proton Pump Inhibitor [EPC] 1 0.0000